Publications

Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH

 77
Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH

Tags:

Previous Article

Human Schwann cell lipid dysregulation and plasma membrane perturbation in Charc...

Next Article

FerroTerminator1 as a potent therapeutic drug for MASH

Related Posts

Rapid nongenomic estrogen signaling controls alcohol drinking behavior in mice

Rapid nongenomic estrogen signaling controls alcohol dr...

 82

Senescent neutrophils: a hidden role in cancer progression

Senescent neutrophils: a hidden role in cancer progression

 64

Roles for primary cilia in synapses and neurological disorders

Roles for primary cilia in synapses and neurological di...

 66